MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202517069764 A) filed by Durect Corporation, Cupertino, U.S.A., on July 22, for 'salts including crystalline salts of 25-hydroxy-cholest-5-en-3-sulfate and methods for preparing same.'
Inventor(s) include Miksztal, Andrew R.; Gonzalez, Mario; Sard, Howard; Lin, Weiqi; and Morency, Cynthia.
The application for the patent was published on Nov. 14, under issue no. 46/2025.
According to the abstract released by the Intellectual Property India: "A number of salts of 25HC3S are provided including crystalline salts of 25HC3S. Included herein are pharmaceutical formulations of salts of the disclosure as well as methods of treating or preventing disease with same such as nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), alcoholic hepatitis, acute kidney injury (AKI), psoriasis, atherosclerosis, hypercholesterolemia, hypertriglyceridemia, alcoholic fatty liver disease (AFLD), alcoholic steatohepatitis (ASH), leptin resistance, leptin deficiency, a diabetes condition, an autoimmune condition, an inflammatory condition, a neurological condition, Epstein Barr virus-related growth, and conditions related to fat accumulation and inflammation. Methods for preparing salts of the disclosure are also provided."
The patent application was internationally filed on Dec. 23, 2022, under International application No.PCT/US2022/053981.
Disclaimer: Curated by HT Syndication.
